dc.contributor.author | Chambers, ES | |
dc.contributor.author | Suwannasaen, D | |
dc.contributor.author | Mann, EH | |
dc.contributor.author | Urry, Z | |
dc.contributor.author | Richards, DF | |
dc.contributor.author | Lertmemongkolchai, G | |
dc.contributor.author | Hawrylowicz, CM | |
dc.date.accessioned | 2020-11-26T15:02:38Z | |
dc.date.available | 2014-03-19 | |
dc.date.available | 2020-11-26T15:02:38Z | |
dc.date.issued | 2014-09 | |
dc.identifier.issn | 0019-2805 | |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/68758 | |
dc.format.extent | 52 - 60 | |
dc.relation.ispartof | IMMUNOLOGY | |
dc.rights | Creative Commons Attribution License | |
dc.rights | Attribution 3.0 Unported (CC BY 3.0) | |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/ | |
dc.subject | 1 alpha,25-dihydroxyvitamin D3 | en_US |
dc.subject | Foxp(3+) regulatory T cells | en_US |
dc.subject | interleukin-2 | en_US |
dc.subject | transforming growth factor-beta | en_US |
dc.title | 1 alpha, 25-dihydroxyvitamin D3 in combination with transforming growth factor-beta increases the frequency of Foxp3(+) regulatory T cells through preferential expansion and usage of interleukin-2 | en_US |
dc.type | Article | en_US |
dc.rights.holder | (c) 2014 The Authors. Immunology published by John Wiley & Sons Ltd | |
dc.identifier.doi | 10.1111/imm.12289 | |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000340385000006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 1 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 143 | en_US |
rioxxterms.funder | Default funder | en_US |
rioxxterms.identifier.project | Default project | en_US |